Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUXSOL Cream for Bacterial Vaginosis
NCT02197182Phase 1Terminated
- Sponsor
- CDA Research Group
- Start
- Jun 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Luxsol in bacterial vaginosis (BV) (2 arms), sponsored by CDA Research Group. Primary endpoint: Presence or absence of bacterial vaginosis at the end of the study at 30 days. Started Jun 2014; status: terminated.
02
Drugs
Luxsol
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT02197182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02197182.